Symposia: Autologous Transplantation: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Hodgkin lymphoma, Acute Myeloid Malignancies, AML, adult, autoimmune disorders, Biological therapies, Lymphomas, non-Hodgkin lymphoma, Clinical Practice (Health Services and Quality), Non-Biological therapies, epidemiology, Clinical Research, B Cell lymphoma, Plasma Cell Disorders, Chemotherapy, Combination therapy, health outcomes research, T Cell lymphoma, pediatric, Checkpoint Inhibitor, Diseases, Immune Disorders, patient-reported outcomes, real-world evidence, Therapies, clinical procedures, registries, Lymphoid Malignancies, young adult , Adverse Events, survivorship, Myeloid Malignancies, Technology and Procedures, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Hodgkin lymphoma, Acute Myeloid Malignancies, AML, adult, autoimmune disorders, Biological therapies, Lymphomas, non-Hodgkin lymphoma, Clinical Practice (Health Services and Quality), Non-Biological therapies, epidemiology, Clinical Research, B Cell lymphoma, Plasma Cell Disorders, Chemotherapy, Combination therapy, health outcomes research, T Cell lymphoma, pediatric, Checkpoint Inhibitor, Diseases, Immune Disorders, patient-reported outcomes, real-world evidence, Therapies, clinical procedures, registries, Lymphoid Malignancies, young adult , Adverse Events, survivorship, Myeloid Malignancies, Technology and Procedures, Study Population, Human, Transplantation
Sunday, December 11, 2022: 9:30 AM-11:00 AM
220-222
(Ernest N. Morial Convention Center)
Moderators:
Joanna Zurko, MD, University of Wisconsin
and
Zohra Nooruddin, MD, Long School of Medicine, University of Texas Health San Antonio
Disclosures:
Nooruddin: Astrazeneca: Research Funding.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH